Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan-1

Omparisons (p < 0.05/6 = 0.0083).<p><b>Copyright information:</b></p><p>Taken from "Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan"</p><p>http://www.biomedcentral.com/1472-6963/8/133</p><p>BMC Health Services Research 2008;8():133-133.</p><p>Published online 18 Jun 2008</p><p>PMCID:PMC2443138.</p><p></p

Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan-4

Omparisons (p < 0.05/6 = 0.0083).<p><b>Copyright information:</b></p><p>Taken from "Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan"</p><p>http://www.biomedcentral.com/1472-6963/8/133</p><p>BMC Health Services Research 2008;8():133-133.</p><p>Published online 18 Jun 2008</p><p>PMCID:PMC2443138.</p><p></p

Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan-2

Omparisons (p < 0.05/6 = 0.0083).<p><b>Copyright information:</b></p><p>Taken from "Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan"</p><p>http://www.biomedcentral.com/1472-6963/8/133</p><p>BMC Health Services Research 2008;8():133-133.</p><p>Published online 18 Jun 2008</p><p>PMCID:PMC2443138.</p><p></p

Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan-3

Omparisons (p < 0.05/4 = 0.0125).<p><b>Copyright information:</b></p><p>Taken from "Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan"</p><p>http://www.biomedcentral.com/1472-6963/8/133</p><p>BMC Health Services Research 2008;8():133-133.</p><p>Published online 18 Jun 2008</p><p>PMCID:PMC2443138.</p><p></p

Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan-0

Omparisons (p < 0.05/4 = 0.0125).<p><b>Copyright information:</b></p><p>Taken from "Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan"</p><p>http://www.biomedcentral.com/1472-6963/8/133</p><p>BMC Health Services Research 2008;8():133-133.</p><p>Published online 18 Jun 2008</p><p>PMCID:PMC2443138.</p><p></p

Extrapolated survival curves of patients with oral squamous cell carcinoma diagnosed for all three groups stratified by gender and before versus after NHI implementation (H:High, M:Middle, and L:Low income ranked group).

Extrapolated survival curves of patients with oral squamous cell carcinoma diagnosed for all three groups stratified by gender and before versus after NHI implementation (H:High, M:Middle, and L:Low income ranked group).</p

Logit transformation of survival ratios between oral cancer patients and age-gender-matched referents from the life table of Taiwan showing the convergence to a straight line and stable slope (the segment near the end indicated by dotted lines), during 12 years follow-up before the establishment of NHI (National Health Insurance) in 1995 by high, middle, and low income ranked.

Logit transformation of survival ratios between oral cancer patients and age-gender-matched referents from the life table of Taiwan showing the convergence to a straight line and stable slope (the segment near the end indicated by dotted lines), during 12 years follow-up before the establishment of NHI (National Health Insurance) in 1995 by high, middle, and low income ranked.</p

Lifetime cumulated incidence rates, aged from 20 to 79 (CIR_20-79), of oral squamous cell carcinoma for males (upper panel) and females (lower panel) stratified by income ranked groups.

Lifetime cumulated incidence rates, aged from 20 to 79 (CIR20-79), of oral squamous cell carcinoma for males (upper panel) and females (lower panel) stratified by income ranked groups.</p

Comparison of life expectancy (LE, in years) and expected years of life loss (EYLL) for patients with oral squamous cell carcinoma for high, middle, and low income groups stratified by gender, before versus after NHI implementation.

Comparison of life expectancy (LE, in years) and expected years of life loss (EYLL) for patients with oral squamous cell carcinoma for high, middle, and low income groups stratified by gender, before versus after NHI implementation.</p

Before NHI: A case of oral squamous cell carcinoma (OSCC) for low income ranked female is on average diagnosed at age of 59.4 (Table 1), while that after National Health Insurance (NHI) is at age of 60.5.

The gain in life expectancy (LE) between before and after NHI would be 13.3–4.6 = 8.7 years. However, if we take two different ages and calendar periods of diagnosis into account by comparing the difference in expected years of life lost (EYLLs) of the above two systems, the potential gain would be 17–10 = 7 years. † indicates mortality.</p